Cresco Labs (CRLBF) Gross Profit Growth (3y) (2023 - 2026)
Cresco Labs (CRLBF) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 0.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.22% |
| Dec 31, 2025 | -1.69% |
| Sep 30, 2025 | -7.14% |
| Jun 30, 2025 | -9.63% |
| Mar 31, 2025 | -9.86% |
| Dec 31, 2024 | -8.59% |
| Sep 30, 2024 | 2.78% |
| Jun 30, 2024 | -2.09% |
| Mar 31, 2024 | 10.28% |
| Dec 31, 2023 | 8.88% |
| Sep 30, 2023 | 17.54% |
| Jun 30, 2023 | 39.72% |